Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
British Journal of Haematology|December 12, 2001
Prolonged immune deficiency following allogeneic stem cell transplantation: risk factors and complications in adult patientsS Maury, J Y Mary, C Rabian, et al.
Bone Marrow Transplantation|April 25, 2001
Influence of CD34(+) marrow cell dose on outcome of HLA-identical sibling allogeneic bone marrow transplants in patients with chronic myeloid leukaemiaR Morariu-Zamfir, V Rocha, A Devergie, et al.
Experimental Hematology|November 8, 2001
Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplantsV Rocha, M V Carmagnat, S Chevret, et al.
Hematology and Cell Therapy|April 1, 1996
Induction chemotherapy followed by allogeneic bone marrow transplantation or aggressive consolidation chemotherapy in childhood acute myeloblastic leukemia. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP)G Michel, A Baruchel, M D Tabone, et al.
British Journal of Haematology|August 29, 1998
Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle studyP Bordigoni, H Esperou, G Souillet, et al.
Blood|November 10, 1998
Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working PartyE Carreras, H Bertz, W Arcese, et al.
British Journal of Haematology|April 1, 1996
A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle OsseuseM Cavazzana-Calvo, P Bordigoni, G Michel, et al.
Pageof 6